Javier Menéndez Menéndez obtained his PhD in Molecular Biology and Biomedicine, in 2021 with the Thesis entitled "Melatonin as a modulator of molecular changes induced by radiotherapy and chemotherapy in the breast cancer”. Thesis committee awarded him with the highest grade and the mentions "cum laude" and "international doctorate" obtained thanks to a collaboration stay at the Barts Cancer Institute of Queen Mary University of London. For this stay he obtained a fellowship from EMBO with the work proposal entitled "Comparative phospho-proteomic analysis of chemotherapy and chemotherapy plus melatonin treated breast cancer cells".
He has participated in the publication of 15 scientific articles, 9 of them are Q1, with an average impact factor of 4.45. In addition, since 2015, he has presented 10 communications at 8 scientific conferences.
Javier Menéndez Menéndez obtained his PhD in Molecular Biology and Biomedicine, in 2021 with the Thesis entitled "Melatonin as a modulator of molecular changes induced by radiotherapy and chemotherapy in the breast cancer”. Thesis committee awarded him with the highest grade and the mentions "cum laude" and "international doctorate" obtained thanks to a collaboration stay at the Barts Cancer Institute of Queen Mary University of London. For this stay he obtained a fellowship from EMBO with the work proposal entitled "Comparative phospho-proteomic analysis of chemotherapy and chemotherapy plus melatonin treated breast cancer cells".
He has participated in the publication of 15 scientific articles, 9 of them are Q1, with an average impact factor of 4.45. In addition, since 2015, he has presented 10 communications at 8 scientific conferences.